Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Edgewise Therapeutics price target lowered to $35 from $40 at Wedbush
Economy

Edgewise Therapeutics price target lowered to $35 from $40 at Wedbush

Last updated: June 28, 2025 6:41 am
Share
Edgewise Therapeutics price target lowered to  from  at Wedbush
SHARE

Wedbush analyst Laura Chico recently adjusted the firm’s price target on Edgewise Therapeutics (EWTX) from $40 to $35, while maintaining an Outperform rating on the stock. The reason for this change stems from the FDA deeming the CANYON data insufficient to support an accelerated filing for sevasemten in Becker muscular dystrophy. Despite this setback, Edgewise is committed to exploring alternative avenues to expedite the process and will now aim for full approval with GRAND CANYON.

According to Chico, there are still several unanswered questions surrounding sevasemten in DMD, particularly regarding the specific patient population to be studied. Wedbush remains optimistic about the potential of sevasemten but acknowledges the need for further clarity on these key aspects.

This news was first reported on TheFly, a leading source for real-time, market-moving financial updates. For those interested in staying informed about the latest stock market trends, TheFly is a valuable resource to consider.

For more information on EWTX and other top-performing stocks, TipRanks offers a comprehensive platform that provides valuable insights and analysis for investors. By visiting TipRanks, users can access real-time data on stock performance and make informed decisions about their investment strategies.

In conclusion, while Edgewise Therapeutics faces challenges in the regulatory process for sevasemten, the company remains dedicated to advancing its treatment for muscular dystrophy. With the support of analysts like Laura Chico from Wedbush, investors can stay informed about the latest developments in the biotech industry.

See also  Best money market account rates today, May 31, 2025 (best account provides 4.41% APY)
TAGGED:EdgewiseLoweredPriceTargetTherapeuticsWedbush
Share This Article
Twitter Email Copy Link Print
Previous Article It’s not just the cities. Extreme heat is a growing threat to rural America. It’s not just the cities. Extreme heat is a growing threat to rural America.
Next Article Man shot, killed at Bucktown park Man shot, killed at Bucktown park
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

RFK Jr. should launch a Marshall Plan for obesity

If Robert F. Kennedy Jr. is confirmed as the secretary of Health and Human Services,…

November 25, 2024

Sen. Cory Booker Leads By Disrupting The Senate For As Long As He Can Stand To Protest Trump

PoliticusUSA remains steadfast in its commitment to provide ad-free content. If you appreciate our work,…

March 31, 2025

Trump Admin Comes Clean About Drones Over New Jersey

The mysterious drone sightings that have been causing speculation and conspiracy theories up and down…

January 29, 2025

CNN’s Kaitlan Collins breaks down in tears during heart-wrenching interview with man whose wife and daughter died in DC plane crash

CNN Anchor Kaitlan Collins Breaks Down in Emotional Interview CNN news anchor Kaitlan Collins was…

February 4, 2025

Runtown Postpones “Soundgod Fest IV” Release

The singer’s candid post comes amid the release of his latest album, “Justice,” in March…

June 18, 2025

You Might Also Like

Canada launches C.4bn minerals push as race to counter China heats up
Economy

Canada launches C$6.4bn minerals push as race to counter China heats up

October 31, 2025
Is Wall Street Bullish or Bearish on Freeport-McMoRan Stock?
Economy

Is Wall Street Bullish or Bearish on Freeport-McMoRan Stock?

October 31, 2025
Dropout Superfan Tier Price Explained by Sam Reich
Entertainment

Dropout Superfan Tier Price Explained by Sam Reich

October 31, 2025
Verizon Communications Stock: Analyst Estimates & Ratings
Economy

Verizon Communications Stock: Analyst Estimates & Ratings

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?